Table 2.
Comparison of disease severity in EOP and LOP
| Variables | Total patients (N = 160) | EOP (N = 121) | LOP (N = 39) | P |
|---|---|---|---|---|
| BSA, % | 3.50 ± 8.65 | 3.34 ± 8.58 | 3.99 ± 8.96 | |
| mean±SD (range) | (0–74.5) | (0.1–74.7) | (0–37.8) | 0.636 |
| PASI | 3.46 ± 6.42 | 3.16 ± 6.07 | 4.37 ± 7.43 | |
| mean±SD (range) | (0–53.10) | (0.2–53.10) | (0–36) | 0.460 |
| Active disease without Rx, months | 24.46 ± 49.59 | 28.62 ± 55.26 | 11.54 ± 20.57 | |
| mean±SD (range) | (0–360) | (0–360) | (0–96) | 0.083 |
| Active disease with Rx, months | 28.29 ± 68.68 | 33.78 ± 77.57 | 11.26 ± 18.32 | |
| mean±SD (range) | (0–492) | (0–492) | (0–72) | 0.334 |
| History of hospitalization | ||||
| Number of positive history, N (%) | 28 (17.5) | 24 (19.8) | 4 (10.3) | 0.171 |
| Number of hospitalizations | 0.38 ± 1.25 | 0.35 ± 0.90 | 0.49 ± 1.99 | |
| mean±SD (range) | (0–12) | (0–5) | (0–12) | 0.380 |
| History of erythroderma | ||||
| number of positive history, N (%) | 12 (7.5) | 11 (9.1) | 1 (2.6) | 0.296 |
| Number of erythroderma | 0.13 ± 0.55 | 0.16 ± 0.61 | 0.05 ± 0.32 | |
| mean±SD (range) | (0–5) | (0–5) | (0–2) | 0.187 |
BSA = body surface area; EOP = early onset psoriasis; LOP = late onset psoriasis; PASI = psoriasis area and severity index; Rx = systemic treatment; SD = standard deviation.